MIRA INFORM REPORT

 

 

Report Date :

20.03.2014

 

IDENTIFICATION DETAILS

 

Name :

BIOCAPITAL CO

 

 

Registered Office :

24 Abbass El Akkad Street, Nasr City, Cairo

 

 

Country :

Egypt

 

 

Financials (as on) :

31.12.2013

 

 

Date of Incorporation :

11.11.2007

 

 

Com. Reg. No.:

385701, Cairo

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

manufacturer of pharmaceuticals and medicines

 

 

No. of Employees

43

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory 

 

 

Payment Behaviour :

No Complaints 

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – december 01, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

Egypt

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

egypt ECONOMIC OVERVIEW

 

Occupying the northeast corner of the African continent, Egypt is bisected by the highly fertile Nile valley, where most economic activity takes place. Egypt's economy was highly centralized during the rule of former President Gamal Abdel NASSER but opened up considerably under former Presidents Anwar EL-SADAT and Mohamed Hosni MUBARAK. Cairo from 2004 to 2008 aggressively pursued economic reforms to attract foreign investment and facilitate GDP growth. Despite the relatively high levels of economic growth in recent years, living conditions for the average Egyptian remained poor and contributed to public discontent. After unrest erupted in January 2011, the Egyptian Government backtracked on economic reforms, drastically increasing social spending to address public dissatisfaction, but political uncertainty at the same time caused economic growth to slow significantly, reducing the government's revenues. Tourism, manufacturing, and construction were among the hardest hit sectors of the Egyptian economy, and economic growth is likely to remain slow during the next several years. The government drew down foreign exchange reserves by more than 50% in 2011 and 2012 to support the Egyptian pound and the dearth of foreign financial assistance - as a result of unsuccessful negotiations with the International Monetary Fund over a multi-billion dollar loan agreement which have dragged on more than 20 months - could precipitate fiscal and balance of payments crises in 2013.

 

Source : CIA

 

 

 

SUMMARY

 

Company Name                                    : BIOCAPITAL CO

Country of Origin                                   : Egypt

Legal Form                                           : Limited Liability Company

Registration Date                                  : 11th November 2007

Commercial Registration Number           : 385701, Cairo

Tax Card Number                                  : 264-688-295

Issued Capital                                       : £E 1,000,000

Paid up Capital                                     : £E 1,000,000

Total Workforce                                     : 43

Activities                                               : Manufacturers of pharmaceuticals and medicines.

Financial Condition                                : Fair

Payments                                             : Nothing detrimental uncovered

Operating Trend                                    : Steady

Person Interviewed                                : Ahmed Tayel, Financial Manager

 

 

 

COMPANY NAME

 

BIOCAPITAL CO

 

 

company ADDRESS

 

Registered & Physical Address

Street               : 24 Abbass El Akkad Street

Area                 : Nasr City

Town                : Cairo

Country             : Egypt

Telephone         : (20-2) 22871991

Facsimile          : (20-2) 22713873

Mobile              : (20-122) 4703860

Email                : egypharma@yahoo.com / egypharmafin@hotmail.com / safy@hefnygroup.com

                           business.development@hefnypharmagroup.com /

 

Premises

Subject operates from a medium sized suite of offices that are rented and located in the Central Business Area of Cairo.

 

Branch Offices

 

Location                                                                                          Description

 

·       26 Noureddine Bahjat Street, 6th Floor, Office No. 13                          Office premises

Extension of Makram Obaid

     Cairo

     Tel: (20-2) 22738310

     Fax: (20-2) 22700260

 

 

KEY PRINCIPALS

 

     Name                                                                                               Position

·       Dr Yasser Hefny Mahmoud Mohamed                                               Chairman

·       Dr Dina Taj Eddine Hassam                                                              Director

·       Dr Hassan Ali                                                                                   General Manager

·       Ahmed Tayel                                                                                    Financial Manager

 

 

LEGAL FORM & OWNERS

 

Date of Establishment  : 11th November 2007 (production started in 2011)

 

Legal Form                  : Limited Liability Company

 

Commercial Reg. No.   : 385701, Cairo

 

Tax Card No.                : 264-688-295

 

Issued Capital              : £E 1,000,000

 

Paid up Capital            : £E 1,000,000

 

Name of Partner (s)                                               

·       Dr Yasser Hefny Mahmoud Mohamed                                              

·       Dr Dina Taj Eddine Hassam

 

 

AFFILIATED COMPANIES

 

·       Egyptian Co For Trading Healthcare & Pharmaceuticals (EGYPHARMA)

24 Abbass El Akkad Street

Nasr City

Cairo

Tel: (20-2) 22871991

 

·       Mira International For Pharmaceutical and Chemicals

24 Abbass El Akkad Street

Nasr City

Cairo

Tel: (20-2) 22871991

 

·       Roto Bio

24 Abbass El Akkad Street

Nasr City

Cairo

Tel: (20-2) 22871991

 

·       Hefny Pharmacies

24 Abbass El Akkad Street

Nasr City

Cairo

Tel: (20-2) 22871991

 

 

OPERATIONS

 

Activities: Engaged in the manufacture of pharmaceuticals and medicines

 

Subject has a workforce of 43 employees.

 

 

FINANCIAL DATA

 

Financial highlights provided by local sources are given below:

 

Currency: Egyptian Pounds (£E)           

 

                                                            Year Ending 31/12/13:

 

Total Sales                                            £E 10,300,000

 

Local sources consider subject’s financial condition to be Fair.

 

The above figures were provided by Mr Ahmed Tayel, Financial Manager. He stated that the expected figure for the year ending 31st December 2014 was £E 11,000,000.

 

 

BANKERS

 

·       Banque Misr

151 Mohamed Farid Street

Cairo

Tel: (20-2) 33912711 / 33912106

Fax: (20-2) 33919779

 

 

PAYMENT HISTORY

 

No complaints regarding subject’s payments have been reported.

 

 

GENERAL COMMENTS

 

Local sources report that the subject’s operating history is clear with payment obligations met in a generally timely manner. The financial position is satisfactory and the company is deemed a fair trade risk.

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

        Rs.61.09

UK Pound

1

Rs.101.41

Euro

1

Rs.85.08

 

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

               

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.